West Pharmaceutical Services Inc. (WST) is a leading global manufacturer specializing in the production of advanced, high-quality, and integrated containment and delivery systems for injectable drugs and healthcare products. The company operates in two primary business segments: Proprietary Products and Contract-Manufactured Products. These segments offer a variety of solutions, including primary packaging, containment systems, reconstitution and transfer systems, drug delivery systems, contract manufacturing, analytical lab services, and integrated...
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | ISRG | Intuitive Surgical Inc | 174.27 Bn | 61.02 | 17.31 | 0.00 Bn |
| 2 | BDX | Becton Dickinson & Co | 59.72 Bn | 37.77 | 3.14 | 19.18 Bn |
| 3 | RMD | Resmed Inc | 39.76 Bn | 26.76 | 7.37 | 0.85 Bn |
| 4 | ALC | Alcon Inc | 38.93 Bn | 37.18 | 3.82 | 5.24 Bn |
| 5 | WST | West Pharmaceutical Services Inc | 17.69 Bn | 133.13 | 12.54 | 0.30 Bn |
| 6 | HOLX | Hologic Inc | 16.81 Bn | 30.91 | 4.07 | 2.52 Bn |
| 7 | COO | Cooper Companies, Inc. | 16.37 Bn | 43.67 | 4.00 | 2.51 Bn |
| 8 | ALGN | Align Technology Inc | 13.73 Bn | 36.29 | 3.45 | 0.09 Bn |
| Current Valuation | Value | Ind Avg | Percentile |
|---|---|---|---|
| EV to Assets EV to Assets | 4.33 | 2.75 | |
| EV to Cash from Ops. EV/CFO | 103.22 | 39.87 | |
| EV to Debt EV to Debt | 59.72 | 27.09 | |
| EV to EBIT EV/EBIT | 89.14 | 32.86 | |
| EV to EBITDA EV/EBITDA | 63.32 | 19.31 | |
| EV to Free Cash Flow [EV/FCF] EV/FCF | 288.54 | 0.88 | |
| EV to Market Cap EV to Market Cap | 1.00 | -4.26 | |
| EV to Revenue EV/Rev | 12.60 | 252.61 | |
| Price to Book Value [P/B] P/B | 18.80 | 6.13 | |
| Price to Earnings [P/E] P/E | 133.13 | 184.03 |
| Dividend Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Dividend Coverage Ratio Div Coverage (Qtr) | 8.10 | -1.09 | |
| Dividend Payout Ratio % Div Payout % (Qtr) | 12.40 | 1.36 | |
| Dividend per Basic Share Div per Share (Qtr) | 0.84 | 0.25 | |
| FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) | 16.00 | 8.74 | |
| Interest Coverage Int. cover (Qtr) | -6,167.00 | -117.83 |
| Growth Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Capex Growth (1y) % Capex 1y % (Qtr) | 17.36 | -53.47 | |
| Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) | 28.03 | 414.02 | |
| Dividend Growth (1y) % Div 1y % (Qtr) | 5.00 | -1.48 | |
| EBIAT Growth (1y) % EBIAT 1y % (Qtr) | -2.40 | -57.42 | |
| EBITDA Growth (1y) % EBITDA 1y % (Qtr) | 4.32 | -106.89 | |
| EBIT Growth (1y) % EBIT 1y % (Qtr) | 1.13 | -37.00 | |
| EBT Growth (1y) % EBT 1y % (Qtr) | 1.98 | -42.63 | |
| EPS Growth (1y) % EPS 1y % (Qtr) | -0.29 | -15.05 | |
| FCF Growth (1y) % FCF 1y % (Qtr) | 17.88 | 56.29 | |
| Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) | 7.04 | 67.95 |
| Liquidity Ratios | Value | Ind Avg | Percentile |
|---|---|---|---|
| Asset Utilization Ratio Asset Util Ratio (Qtr) | 0.74 | 0.54 | |
| Cash Payout Ratio Cash Payout (Qtr) | 0.06 | 0.03 | |
| Cash Ratio Cash Ratio (Qtr) | 0.99 | 2.51 | |
| Current Ratio Curr Ratio (Qtr) | 2.87 | 7.80 | |
| Debt to Equity Ratio Debt/Equity (Qtr) | 0.10 | 0.55 | |
| Interest Cover Ratio Int Coverage (Qtr) | -6,167.00 | -117.83 | |
| Times Interest Earned Times Interest Earned (Qtr) | -6,167.00 | -117.83 |
| Profitability | Value | Ind Avg | Percentile |
|---|---|---|---|
| EBITDA Margin % EBITDA Margin % (Qtr) | 25.90 | -2,368.59 | |
| EBIT Margin % EBIT Margin % (Qtr) | 20.43 | -2,472.59 | |
| EBT Margin % EBT Margin % (Qtr) | 20.44 | -2,442.52 | |
| Gross Margin % Gross Margin % (Qtr) | 35.60 | 30.06 | |
| Net Profit Margin % Net Margin % (Qtr) | 16.30 | -2,438.49 |